These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3703462)

  • 1. Acute leukemia after treatment for ovarian cancer. Report of four cases and review of the literature.
    De Gramont A; Remes P; Krulik M; Smadja N; Drolet Y; Donadio D; Louvet C; Brissaud P; Sirinelli A; Dray C
    Oncology; 1986; 43(3):165-72. PubMed ID: 3703462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukemia following prolonged cytotoxic agent therapy.
    Casciato DA; Scott JL
    Medicine (Baltimore); 1979 Jan; 58(1):32-47. PubMed ID: 105227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of acute nonlymphocytic leukaemia (ANLL) in myelomatosis.
    Drivsholm A; Lisse I; Philip P
    Scand J Haematol; 1985 Jul; 35(1):35-7. PubMed ID: 4048861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemia after alkylating-agent therapy of ovarian cancer.
    Reimer RR; Hoover R; Fraumeni JF; Young RC
    N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
    Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ
    N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia following chemotherapy for breast cancer.
    Curtis RE; Boice JD; Moloney WC; Ries LG; Flannery JT
    Cancer Res; 1990 May; 50(9):2741-6. PubMed ID: 2328500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemogenesis related to chemotherapy of ovarian carcinoma: a review with three new case reports.
    Littleton RE; Homesley HD; Richards F
    Gynecol Oncol; 1984 Nov; 19(3):268-77. PubMed ID: 6389274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloblastic leukemia following treatment for non-hematopoietic cancers: report of 19 cases and review of the literature.
    Zarrabi MH; Rosner F
    Am J Hematol; 1979; 7(4):357-67. PubMed ID: 296652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential appearance of immunoblastic lymphoma and acute nonlymphocytic leukemia in a patient with angioimmunoblastic lymphadenopathy.
    Pereira A; Cervantes F; Viñolas N; Llebaría C; Pedro-Botet J; Rozmann C
    Acta Haematol; 1985; 74(3):175-7. PubMed ID: 3938163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
    Le Beau MM; Albain KS; Larson RA; Vardiman JW; Davis EM; Blough RR; Golomb HM; Rowley JD
    J Clin Oncol; 1986 Mar; 4(3):325-45. PubMed ID: 3950675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related leukemia. A report of five patients and a review of the literature.
    Advani SH; Doval DC; Gopal R; Nair CN; Kutty PM
    Oncology; 1983; 40(4):268-72. PubMed ID: 6346196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases.
    De Gramont A; Louvet C; Krulik M; Smadja N; Donadio D; Laporte JP; Brissaud P; Smith M; Delâge JM; Drolet Y
    Cancer; 1986 Aug; 58(3):630-4. PubMed ID: 3731020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
    Sotrel G; Jafari K; Lash AF; Stepto RC
    Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.
    Pedersen-Bjergaard J; Specht L; Larsen SO; Ersbøll J; Struck J; Hansen MM; Hansen HH; Nissen NI
    Lancet; 1987 Jul; 2(8550):83-8. PubMed ID: 2885581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of secondary acute nonlymphocytic leukemias. Cytological aspects (a review).
    Raposa T; Várkonyi J; Gráf F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):180-5. PubMed ID: 6208100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies of bone marrow in breast cancer patients after adjuvant chemotherapy.
    Nowell P; Glick JH; Bucolo A; Finan J; Creech R
    Cancer; 1981 Aug; 48(3):667-73. PubMed ID: 7248894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural characteristics of therapy-related acute nonlymphocytic leukemia: evidence for a panmyelosis.
    McKenna RW; Parkin JL; Foucar K; Brunning RD
    Cancer; 1981 Aug; 48(3):725-37. PubMed ID: 7248900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukaemia after alkylating-agent therapy of ovarian cancer.
    Bell DR; Woods RL; Levi JA
    Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.
    Chambers SK; Chopyk RL; Chambers JT; Schwartz PE; Duffy TP
    Cancer; 1989 Dec; 64(12):2459-61. PubMed ID: 2819655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.